1/28
Looks like no tags are added yet.
pharmacogenomics
the study of genetic factors that underlie variation in drug response
entire GENOME effects
implies a recognition that more than one genetic variant may contribute to variation in drug response
precision medicine
stratified or personalized medicine, in which genetic information is used to guide drug and dosing selection for subgroups of patients or individual patients in medical practice
allele
One of two or more alternative forms of a gene that arise by mutation and are found at the same genetic locus. Example: CYP2D6*3 is an important variant allele for a drug-metabolizing enzyme, CYP2D6.
allele frequency
The fraction or percentage that a specific allele is observed in proportion to the total of all possible alleles in a population.
Coding single nucleotide polymorphisms (cSNPs)
A single base-pair substitution that occurs in the coding region
Copy number variations (CNVs)
A segment of DNA in which a variable number of that segment has been found.
haplotype
A series of alleles found in a linked locus on a chromosome.
Hardy-Weinberg equilibrium
The principle that allele frequencies will remain constant from generation to generation in the absence of evolutionary influences.
Insertion/Deletion (indel)
Insertion or deletion of base pairs, which may occur in coding and noncoding regions.
Linkage Disequilibrium
The nonrandom association of alleles at two or more loci that descend from a single ancestral chromosome.
Noncoding Region Polymorphism
Polymorphisms that occur in the 3′ and 5′ untranslated regions, intronic regions, or intergenic regions.
Nonsynonymous SNPs (nsSNPs)
A single base-pair substitution in the coding region that results in an amino acid change.
Polymorphism or variant
Any genetic variation in the DNA sequence; the terms can be used interchangeably.
PM, IM, EM, or UM
Poor, intermediate, extensive, or ultrarapid metabolizer phenotype.
Single Nucleotide Polymorphisms -SNPs
base-pair substitutions that occur in the genome.
Synonymous SNPs
Base-pair substitutions in the coding region that do not result in an amino acid change.
Genotype
Set of alleles for a particular gene
Phenotype
observable or functional traits (depends on genotype and environmental factors)
Gene
Unit of hereditary that is transferred from a parent to offspring and determines characteristics in the offspring
PK pharmacogenomics
Absorption -transporter variation
Distribution -transport proteins
Metabolism -CYP enzyme activity
Distribution -transporters and renal proteins
PD pharmacogenetics
Receptor binding -altered receptor structure
Drug effect -different sensitivity
Mutation
Process that produces a gene or chromosome that differed from WT (rarer than SNPs)
Actionable pharmacogenomics
Genetic into that could be used to change drug therapy (25 genes)
Codeine Metabolism
Codeine (prodrug) is converted to morphine (active metabolite) by CYP2D6
UM → high morphine exposure, potential toxicity
PM → low morphine exposure, therapeutic failure
Warfarin Pharmacogenomics
pharmacodynamics: VKORC1 = drug target, variant alters warfarin sensitivity (may need lower dose)
pharmacokinetics: CYP2C9 = metabolizes warfarin, *2 or *3 variants metabolize slower and have increased bleeding risk, reduced function variants slow drug clearance
Genetic drift
Random change in allele frequency from one generation to the next due to sampling effort in small populations independent of an alleles adaptive value
Bottleneck effect
Sharp reduction in an existing populations size due to a random environmental disaster leaving a small, randomly surviving group
Founder effect
Special case of genetic drift where a tiny subgroup detaches from main population and colonizes a new isolated area
Positive selection
Deterministic evolutionary process where a beneficial allele increases in frequency bc it improves fitness (non random)